Investigating respiratory viruses in patients with acute heart failure
Official title: Respiratory Virus Infections in Hospitalized Patients With Acute Heart Failure Syndrome: A Prospective Multi-center Observational Study
Run by Seoul National University Bundang Hospital · NCT06967441 · Data updated 2026-11-12
This study looks at whether respiratory viruses like the flu and COVID-19 are present in adults with acute heart failure to see how these infections might affect their heart condition.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 19 Years and up |
| Sex | All |
| Enrollment | 360 (estimated) |
| Sponsor | Seoul National University Bundang Hospital Academic / other |
| Locations | 3 sites (Seongnam-si, Gyeonggi-do and 2 other locations) |
| Status | Recruiting |
| Started | April 7, 2025 |
| Main results expected | December 31, 2028 |
| Study ends | December 31, 2028 |
| Registry record updated | March 11, 2026 |
| Trial ID | NCT06967441 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 19 years or older with acute heart failure and suspected respiratory viral infections.
✕Probably not a fit
Patients with clear alternative causes of acute heart failure or other sources of infection may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study enrolls adult patients admitted to the cardiology department with acute heart failure who have undergone a nasopharyngeal respiratory virus PCR test within 72 hours of admission. The study aims to analyze the detection rates of various respiratory viruses, including influenza, RSV, and coronaviruses, and to observe seasonal variations in their frequency. Additionally, it will assess how respiratory virus infections may influence the clinical presentation of acute heart failure. The findings could provide insights into the interplay between respiratory infections and heart failure.
Why it matters
Potential benefit: If successful, this study could enhance understanding of respiratory virus impacts on acute heart failure, potentially leading to improved patient management strategies.
How similar studies have gone: While similar studies have explored respiratory infections in heart failure, this specific observational approach focusing on viral detection rates is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult aged 19 years or older admitted to the cardiology department with acute heart failure * NT-proBNP \>300 pg/mL * Clinician judgement of possible respiratory viral infection (fever \>38 degrees or cough, respiratory symptoms such as sputum or consolidation on x-ray or CRP \>5 mg/dL) * Patients who have a nasopharyngeal swab for respiratory virus PCR test performed within 72 hours of admission for any of the 3 reasons Exclusion Criteria: * Patients with a clear other cause of acute heart failure (ex. ACS, bradycardia requiring a pacemaker, uncontrolled tachycardia, uncontrolled severe hypertension (SBP \>180mmHg or DBP \>110mmHg), haemoglobin \<7g/dL or AHF precipitated by medication non-adherence) * If the cause of pulmonary oedema is prominently attributed to exacerbation of CKD * If there is a clear other source of infection that can explain the fever
Where it's running
-
Seoul National University Bundang Hospital
Seongnam-si, Gyeonggi-do, South Korea Recruiting -
Samsung medical center
Seoul, South Korea Recruiting -
Seoul ST. Mary's Hospital
Seoul, South Korea Recruiting
Study contacts
- Study coordinator: Minjae Yoon, MD
- Email: minjae1677@gmail.com
- Phone: +82-10-6334-1917
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Infusion of furosemide to see if a loading infusion helps remove fluid better in acute heart failure
This study tests whether giving furosemide as a continuous infusion with a loading dose is better at removing excess fluid than giving it as bolus injections in adults with acute heart failure.
-
Characterizing phenotypes of acute heart failure
This project will try to see if heart function measures, imaging features (radiomics), and blood biomarkers can predict outcomes for adults hospitalized with acute heart failure, including cardiogenic shock.
-
Early finerenone treatment for hospitalized adults with acute heart failure and LVEF ≥40%
This trial will test whether starting finerenone early during hospitalization helps adults with acute heart failure who have a left ventricular ejection fraction of 40% or higher.
-
Intensive GDMT optimization for women after heart failure hospitalization
This study tests whether rapidly increasing and closely monitoring heart failure meds in women after hospitalization can reduce death or readmission within a year.
-
Using intra‑abdominal pressure and bedside ultrasound to guide decongestive treatment in heart failure
This trial will test whether using bladder pressure (intra‑abdominal pressure) measurements together with bedside ultrasound to guide IV loop diuretics helps people hospitalized with acute heart failure get rid of excess fluid more effectively than usual care.
-
Investigating heart issues in COPD patients during hospital stays
This study is trying to see if sudden worsening of COPD can cause heart problems in hospitalized patients and how it affects their recovery.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.